Delivery Order SPE2DB22D1017-SPE2DB25FF4TU

Award Date 2/4/25
Potential Completion Date 2/5/25
Potential Value $8.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ISOTRETINOIN 30 MG CAPSULE 30S. The contract, valued at $8,440.66, was awarded on June 4, 2025 by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 5, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $2,874.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ISOTRETINOIN 30 MG CAPSULE 30S, a pharmaceutical product, with a performance period through February 7, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
The federal contract award is for the delivery of ISOTRETINOIN 30 MG CAPSULE 30S to the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,647.08. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded on December 12, 2024, is a delivery order valued at $1,427.27 with a firm fixed price. It is for the supply of 4566709046 ISOTRETINOIN 30 MG CAPSULE 30S, with a completion date of December 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,729.28 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,894,730 units of the prescription medication ISOTRETINOIN 30 MG CAPSULE 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC...
This federal contract award is for the delivery of ISOTRETINOIN 30 MG CAPSULE 30S to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $5,350.98 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. This contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds...
This federal contract award is for the delivery of Isotretinoin 20 mg capsules to the Defense Logistics Agency (DLA). The $1,498.67 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of ISOTRETINOIN 30 MG CAPSULE 30S, a medication, with a ceiling value of $3,018.64 and an ultimate completion date of May 28, 2025. The contract is a Delivery Order and is priced on a Firm Fixed Price basis. This contract is not set-aside. Amerisourcebergen Drug Corp is the prime...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ISOTRETINOIN 30 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $3,320.30. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of March 20, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug...
This federal contract award, with an ID of SPE2DB22D1052|SPE2DB24FU9LA, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ISOTRETINOIN 30 MG CAPSULE 30S, a medical product, with a ceiling value of $8,564.45 and a performance period ending on July 22, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF4TU
    Delivery Order

This federal contract award is for the delivery of 4,567,157,085 units of ISOTRETINOIN 30 MG CAPSULE 30S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $8,612.47 and runs from February 4, 2025 to February 5, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/21/25, 10:16 AM